In Other News

• Stronger Laboratory Services Support Timely Melioidosis Diagnosis Amid Global Spread

• Lab-on-a-Chip Approach Advances Immune–Cancer Cell Interaction Analysis

• Maternal Blood Biomarkers Identify Risk of Preterm and Early-Term Birth

• Blood-Based Alzheimer’s Testing Platform Offers Rapid Results

• Genetic Testing Identifies High-Risk Patients with Inflammatory Bowel Disease

• QIAGEN Enhances QIAcuity Platform with Gene Expression and Multiplexing Tools

• Extracellular Vesicle Biomarker May Enable Noninvasive Monitoring of H. pylori

• Ancestry-Informed Genomics Advances Precision Cancer Prognosis

• Genetic Testing Identifies High-Risk Patients with Inflammatory Bowel Disease

• Extracellular Vesicle Biomarker May Enable Noninvasive Monitoring of H. pylori

• New Blood Test Predicts Organ-Specific Disease and Mortality Years in Advance

• Genomic Assay Predicts Recurrence Risk in Noninvasive Breast Cancer

• Stain-Free Imaging Platform Matches Standard Cancer Pathology

• New Findings Clarify Molecular Drivers of Rare Small Intestinal Cancer

• Partnership Expands Ultrasensitive Blood-Based Diagnostics for Hematologic Malignancies

• New Blood Test Predicts Organ-Specific Disease and Mortality Years in Advance

• Long-Read DNA Test Improves Diagnosis of Rare Genetic Diseases

• New Companion Diagnostic Expands Precision Medicine in Prostate Cancer

• Antibody Profiles Provide Clues to Long COVID Severity and Symptoms

• At-Home Urine Collection Kit Enables High-Throughput STI Screening

• Noninvasive Sequencing Test Approaches Invasive Genome Sequencing for Prenatal Screening

• Blood-Based Assay Detects HER2 Mutations to Guide NSCLC Treatment

• Rapid Molecular Screening Aims to Accelerate Hospital Infection Control for CPE